110 related articles for article (PubMed ID: 16768055)
21. [Preeclampsia--possibly prediction markers].
Vokroj J; Arnostová L
Ceska Gynekol; 2009 Aug; 74(4):256-61. PubMed ID: 20564978
[TBL] [Abstract][Full Text] [Related]
22. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in ovarian cancer.
Tropé C
Cancer Treat Res; 1998; 95():287-352. PubMed ID: 9619290
[No Abstract] [Full Text] [Related]
24. [Current aspects of diagnosis, therapy and follow-up care of ovarian carcinoma].
Lotze W
Z Arztl Fortbild (Jena); 1991 Mar; 85(6):242-5. PubMed ID: 2038849
[No Abstract] [Full Text] [Related]
25. Is serum CA 125 at the time of relapse a prognostic indicator for further survival prognosis in patients with ovarian cancer?
Makar AP; Kristensen GB; Børmer OP; Tropé CG
Gynecol Oncol; 1993 Apr; 49(1):3-7. PubMed ID: 8482556
[TBL] [Abstract][Full Text] [Related]
26. [Transitional cell carcinoma of the ovary: one kind of uncommon type of ovarian epithelial carcinoma].
Wu M; Shen K; Lang J; Huang R; Huang H; Pan L
Zhonghua Fu Chan Ke Za Zhi; 2002 Dec; 37(12):733-5. PubMed ID: 12622917
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of recurrent ovarian cancer].
Robová H; Rob L; Pluta M; Halaska M; Chmel R
Ceska Gynekol; 2009 Dec; 74(6):464-8. PubMed ID: 21246797
[TBL] [Abstract][Full Text] [Related]
28. [Para-aortic lymphadenectomy in gynecology. Theoretical principles, basic approach and practical suggestions].
Spacek J; Veselský Z; Tosner J; Tesarík Z
Ceska Gynekol; 2003 Mar; 68(2):99-105. PubMed ID: 12749178
[TBL] [Abstract][Full Text] [Related]
29. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors of common epithelial ovarian cancer treated by surgery and cisplatin based combination chemotherapy].
Sasaki H; Ochiai K; Terashima Y; Mochizuki S; Soda T; Nishimura H; Yakushiji M; Hirabayashi M
Gan No Rinsho; 1989 Oct; 35(13):1615-20. PubMed ID: 2585733
[TBL] [Abstract][Full Text] [Related]
31. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
32. Contribution of immunohistochemistry in prognostic assessment of epithelial ovarian carcinoma --review of the literature I.
Tomsová M; Melichar B
Acta Medica (Hradec Kralove); 2006; 49(3):161-5. PubMed ID: 17117604
[TBL] [Abstract][Full Text] [Related]
33. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
Venesmaa P
Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
[TBL] [Abstract][Full Text] [Related]
34. [Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
Huang X; Cai SM; Tang J; Li ZT; Zang RY
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):602-5. PubMed ID: 15498187
[TBL] [Abstract][Full Text] [Related]
35. Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013.
Aoki D
J Obstet Gynaecol Res; 2014 Feb; 40(2):338-48. PubMed ID: 24472052
[TBL] [Abstract][Full Text] [Related]
36. [A new opportunity in ovarian cancer treatment].
Sedláková I
Ceska Gynekol; 2012 Oct; 77(5):469-71. PubMed ID: 23116353
[TBL] [Abstract][Full Text] [Related]
37. [Immunotherapy--perspectives in therapy of ovarian carcinomas].
Zapletalová K; Tobiasová Z; Spísek R; Rob L; Bartůnková J
Ceska Gynekol; 2004 Sep; 69(5):372-5. PubMed ID: 15587893
[TBL] [Abstract][Full Text] [Related]
38. [Risk factors for recurrent disease in borderline ovarian tumors].
Líbalová P; Vernerová Z; Hubicková-Heringová L; Pintérová D; Tikovský K; Kubecová M; Svoboda B
Ceska Gynekol; 2012 Feb; 77(1):31-5. PubMed ID: 22536638
[TBL] [Abstract][Full Text] [Related]
39. [Vascular endothelial growth factor in ovarian cancer patients].
Sedláková I; Tošner J; Kopecký O; Vroblová V; Rezáč A; Skapinec P; Andrýs C
Ceska Gynekol; 2012 Oct; 77(5):415-20. PubMed ID: 23116346
[TBL] [Abstract][Full Text] [Related]
40. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
